VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

CatalYm

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

Pioneers in neutralizing GDF-15 to reverse key immune resistance mechanisms to cancer therapies

Also known as CatalYm GmbH

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Business model
B2B
Headquarters
Planegg-Martinsried, Germany
Legal name
CatalYm GmbH
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

CatalYm has identified GDF-15 as a key cancer therapy resistance mechanism and is developing a safe and efficacious immune therapy for solid tumors.

Products

Other
visugromab
Web
Visugromab
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy